At Consensus Hong Kong 2026, industry leaders from Paradigm and Blockdaemon argue that temporary centralization is not a ...

Espresso Systems tackles Rollup fragmentation and centralized sequencing with HotShot consensus, enabling cross-chain composability.

One of Bitcoin’s undeniable and frequently touted strengths is its decentralization. It’s often claimed that the Bitcoin network offers levels of decentralization, accessibility, and distribution ...

Forbes contributors publish independent expert analyses and insights. Maximal Extractable Value — more widely referred to as simply MEV — has become a pivotal issue, particularly within the Ethereum ...

Decentralized networks are becoming commonplace on today's technical landscape, as enterprises seek to write custom applications that solve business problems. Increasingly these are based on smart ...

The field of artificial intelligence (AI) is taking the world by storm, but many people have found themselves looking up at the sky, wondering where all the rain came from. Those who didn’t realize ...

When it launched in 2009, Bitcoin (CRYPTO: BTC) was designed to be a decentralized, peer-to-peer digital currency. In fact, Bitcoin was so decentralized that it was considered to be beyond the reach ...

OpenAI's SORA has captivated public attention, showcasing the transformative power of AI and its capacity to reshape our world once again. In the realm of cryptocurrency and blockchain, decentralized ...

A new working paper from Nobel laureate James A. Robinson finds a vast landscape of 45,000 polities—deliberately fragmented to protect local autonomy ...

Decentralization is transforming how we think about power, trust, and decision-making. For several decades, it was common to see most systems in place, including government, banking, industry, and ...

Over half of global population lives in cities, and this ratio is continually increasing. In the context of achieving carbon neutral in the middle of 21th, cities are both an important cause for and ...

A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease Strategies to bring clinical trials closer to patients gained ...